Literature DB >> 8616978

Desogestrel.

S C Stone1.   

Abstract

Desogestrel is a new, potent progestogen with very low androgenic properties. When used as a contraceptive, it is a strong antiovulatory compound, even at low doses. The clinical efficacy is as good as that of the old progestogens. It has a low incidence of side effects and complications, similar to other progestogens. It may have a role as an anti-androgen in women with hyperandrogenic symptoms in need of adequate oral contraception.

Entities:  

Keywords:  Biology; Blood Coagulation Effects; Carbohydrate Metabolic Effects; Cardiovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Desogestrel; Family Planning; Hematological Effects; Hemic System; Lipid Metabolic Effects; Lipids; Literature Review; Metabolic Effects; Physiology

Mesh:

Substances:

Year:  1995        PMID: 8616978     DOI: 10.1097/00003081-199538040-00017

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  3 in total

Review 1.  Contraception across transgender.

Authors:  Ilaria Mancini; Stefania Alvisi; Giulia Gava; Renato Seracchioli; Maria Cristina Meriggiola
Journal:  Int J Impot Res       Date:  2021-02-08       Impact factor: 2.896

2.  Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.

Authors:  Jessica R Meendering; Britta N Torgrimson; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Contraception       Date:  2008-10-28       Impact factor: 3.375

3.  The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial.

Authors:  Nisarath Soontrapa; Manee Rattanachaiyanont; Malee Warnnissorn; Thanyarat Wongwananuruk; Suchada Indhavivadhana; Prasong Tanmahasamut; Kitirat Techatraisak; Surasak Angsuwathana
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.